Results 21 to 30 of about 1,252,486 (261)
Journal of Hospital Infection, 2021 COVID-19-associated pulmonary aspergillosis (CAPA) is defined as invasive pulmonary aspergillosis occurring in COVID-19 patients. The purpose of this review was to discuss the incidence, characteristics, diagnostic criteria, biomarkers, and outcomes of ...
W. Chong, Kristoffer P. Neu
semanticscholar +1 more source
TOO MANY MOULDY JOINTS – MARIJUANA AND CHRONIC PULMONARY ASPERGILLOSIS
Mediterranean Journal of Hematology and Infectious Diseases, 2011 Chronic pulmonary aspergillosis is a progressive debilitating disease with multiple underlying pulmonary diseases described. Here we report the association of chronic pulmonary aspergillosis and long term marijuana smoking in 2 patients and review the ...
Youssef Gargani +2 more
doaj +3 more sources
Influenza associated pulmonary aspergillosis in california: A case series
Clinical Infection in Practice, 2022 Introduction: Invasive pulmonary aspergillosis has been reported to occur in patients who are critically ill with severe influenza. The mortality rate is high.
John Z. Deng +8 more
doaj +1 more source
Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
Medical Mycology Case Reports, 2021 Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids.
Andre K. Johnson +3 more
semanticscholar +1 more source
Aspergillus Section Fumigati Pneumonia and Oxalate Nephrosis in a Foal
Pathogens, 2021 Equine pulmonary aspergillosis is a rare deep mycosis often due to the hematogenous spread of hyphae after gastrointestinal tract disease. We describe herein the main clinic-pathological findings observed in a foal, which spontaneously died after showing
Jasmine Hattab +8 more
doaj +1 more source
COVID‐19 associated pulmonary aspergillosis
Mycoses (Berlin), 2020 Patients with acute respiratory distress syndrome (ARDS) due to viral infection are at risk for secondary complications like invasive aspergillosis.
P. Koehler +13 more
semanticscholar +1 more source
Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis
Emerging Infectious Diseases, 2021 We performed an observational study to investigate intensive care unit incidence, risk factors, and outcomes of coronavirus disease–associated pulmonary aspergillosis (CAPA). We found 10%–15% CAPA incidence among 823 patients in 2 cohorts.
N. Janssen +31 more
semanticscholar +1 more source
Allergic bronchopulmonary aspergillosis: diagnostic and treatment challenges [PDF]
, 2016 Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder, occurring mostly in asthmatic and cystic fibrosis patients, caused by an abnormal T-helper 2 lymphocyte response of the host to Aspergillus fumigatus antigens.
CINICOLA, BIANCA LAURA +3 more
core +1 more source
COVID-19 Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients
Clinical Infectious Diseases, 2021 Background COVID-19 associated pulmonary aspergillosis (CAPA) occurs in critically ill COVID-19 patients. Risks and outcomes remain poorly understood.
N. Permpalung +8 more
semanticscholar +1 more source
Necrotizing pulmonary aspergillosis [PDF]
Thorax, 1970 Necrotizing or invasive aspergillary infection of the lungs has previously been considered a rare condition affecting only the debilitated or seriously ill. Four patients with necrotizing pulmonary aspergillosis are described, and the mycological and histopathological findings are discussed.
W P, Kennedy, D N, Malone, W, Blyth
openaire +2 more sources